RPS supports availability of sildenafil in pharmacies

Martin Astburyby RPS President Martin Astbury

The MHRA have today posted a consultation about the switch of sildenafil from a prescription only medicine to a pharmacy medicine, which means it must be sold under the supervision of a pharmacist.

The Royal Pharmaceutical Society fully supports the application for sildenafil to move from prescription only (POM) to pharmacy medicine (P) status so it can be provided directly by pharmacists for erectile dysfunction (ED). Read more RPS supports availability of sildenafil in pharmacies